Ejaculation Clinical Trial
Official title:
A Phase 2 Multi-Center, Open Label Long-Term Extension Trial To Assess The Safety Of Oral Uk-390,957 Administered As Required In Adult Men With Premature Ejaculation
To determine whether UK-390,957 is a safe treatment for premature ejaculation.
n/a
Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01021670 -
An Observational Study of Men With Premature Ejaculation Who Are Treated With Dapoxetine Hydrochloride or Alternate Care Defined as Any Treatment Other Than Dapoxetine Hydrochloride
|
Phase 4 | |
| Completed |
NCT00210613 -
A Study of Withdrawal Effects With Dapoxetine in the Treatment of Premature Ejaculation
|
Phase 3 | |
| Completed |
NCT00211107 -
A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation.
|
Phase 3 | |
| Completed |
NCT00219635 -
Assessment Of Efficacy and Safety UK-390,957 In Men With Premature Ejaculation
|
Phase 2/Phase 3 | |
| Terminated |
NCT02918227 -
Exploration of Ejaculation Changing Mechanism After Surgery for Benign Prostatic Hyperplasia
|
N/A | |
| Completed |
NCT00143117 -
Assessment of Efficacy and Safety of UK-390,957 in Men With Premature Ejaculation
|
Phase 2/Phase 3 | |
| Completed |
NCT00219583 -
Assessment Of Efficacy and Safety Of UK-390,957 In Men With Premature Ejaculation
|
Phase 2/Phase 3 | |
| Completed |
NCT01366664 -
A Pharmacodynamic Study of Dapoxetine Concomitantly Administered in Participants Taking Terazosin
|
Phase 1 | |
| Completed |
NCT01230762 -
An Open-Label Study of the Long-Term Safety of Dapoxetine HCl in the Treatment of Rapid Ejaculation
|
Phase 3 | |
| Completed |
NCT00211094 -
A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation
|
Phase 3 |